Company / Tangible Book Value per Share
BeOne Medicines Ltd. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.14
FY2025
5-year range
$2.45 / $5.08
FY2021-FY2025
Trend
+28.3%
vs FY2024
Sector context
#124 of 209
Health Care
What the data says
At $3.14, BeOne Medicines Ltd.'s tangible book value per share ranks #124 of 209 in the Health Care sector. Tangible Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $3.14.
Based on SEC 10-K filings.
3.14 in FY2025 with a 5-year CAGR of -8.2%.
Improved from $2.61 to $3.14 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -1.4%
- 5-Year CAGR
- -8.2%
- 10-Year CAGR
- -
Sector benchmark
#124 of 209 in Health CareTop 59% of 209This company $3.14 Sector average $119.74
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 28.3% year-over-year.
- Ranks #124 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | +28.3% |
| FY2024 | $2.45 | -6.0% |
| FY2023 | $2.61 | -20.6% |
| FY2022 | $3.28 | -35.4% |
| FY2021 | $5.08 | +5.3% |
| FY2020 | $4.83 | +289.6% |
| FY2019 | $1.24 | -57.8% |
| FY2018 | $2.94 | +126.2% |
| FY2017 | $1.30 | -57.3% |
| FY2016 | $3.04 | +430.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026